Erenumab effectiveness and safety: comparison of real-life data and clinical trial results
Background. Erenumab was the first preventive medication targeted to the pathogenesis of migraine to reach Lithuanian market. Previously, evidence of the safety and efficacy of erenumab was supported only by clinical study results, but more recently, real-life data started to appear. The aim of thi...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Vilnius University Press
2021-12-01
|
| Cyfres: | Neurologijos seminarai |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/27594 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|